Search Results
Apr 09, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines - CORT
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-corcept-therapeutics-incorporated-of-class-action-lawsuit-and-upcoming-deadlines--cort-302737805.htmlSOURCE
More news about: Pomerantz LLP
Apr 07, 2026, 12:15 ET Corcept (CORT) Class Action Alleges Misstatements on FDA Data Concerns - Hagens Berman
Corcept common stock between October 31, 2024, and December 30, 2025 (the "Class Period").Investors in Corcept (CORT) are encouraged to visit the Hagens Berman's CORT Case Page to review the allegations:
More news about: Hagens Berman Sobol Shapiro LLP
Apr 07, 2026, 12:00 ET Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
CORT). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CORCEPT THERAPEUTICS INCORPORATED (CORT), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE APRIL 21, 2026 (LEAD PLAINTIFF DEADLINE)
More news about: Law Offices of Howard G. Smith
Apr 07, 2026, 09:00 ET CORT Shareholder Alert: April 21, 2026 Lead Plaintiff Deadline in Corcept Therapeutics Incorporated Securities Class Action Lawsuit -- The Gross Law Firm
2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Corcept Therapeutics Incorporated (NASDAQ: CORT).
More news about: The Gross Law Firm
Apr 07, 2026, 03:41 ET CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April 21, 2026 lead plaintiff deadline.So what:
More news about: THE ROSEN LAW FIRM, P. A.
Apr 06, 2026, 12:00 ET Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
CORT) have opportunity to lead the securities fraud class action lawsuit.
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Apr 06, 2026, 12:00 ET CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
More news about: The Schall Law Firm
Apr 06, 2026, 03:59 ET Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT
CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CORT during the class period listed are encouraged
More news about: DJS Law Group LLP
Apr 03, 2026, 20:52 ET Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT
Corcept Therapeutics Incorporated (NasdaqCM: CORT) ("Corcept" or the "Company"), if they purchased or otherwise acquired the Company's shares between October 31, 2024 and December 30, 2025, inclusive
More news about: ClaimsFiler
Apr 03, 2026, 18:28 ET Corcept (CORT) Class Action Alleges Misstatements on FDA Data Concerns - Hagens Berman
Corcept common stock between October 31, 2024, and December 30, 2025 (the "Class Period").Investors in Corcept (CORT) are encouraged to visit the Hagens Berman's CORT Case Page to review the allegations:
More news about: Hagens Berman Sobol Shapiro LLP
Apr 02, 2026, 11:37 ET Waste Pro USA, Inc. Announces the Reoffering of $120.0 million of Solid Waste Disposal Revenue Bonds
continue to serve as a cornerstone of Waste Pro's capital structure, and optimizing our balance sheet with long-term debt remains a priority," stated Cort Sabina, Chief Financial Officer of Waste Pro. "Executing a successful $120.0 million reoffering in such a dynamic market environment speaks to the strength
More news about: Waste Pro USA, Inc.
Apr 02, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines - CORT
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-corcept-therapeutics-incorporated-of-class-action-lawsuit-and-upcoming-deadlines--cort-302732439.htmlSOURCE
More news about: Pomerantz LLP
Apr 01, 2026, 15:23 ET Corcept (CORT) Class Action Alleges Misstatements on FDA Data Concerns - Hagens Berman
Corcept common stock between October 31, 2024, and December 30, 2025 (the "Class Period").Investors in Corcept (CORT) are encouraged to visit the Hagens Berman's CORT Case Page to review the allegations:
More news about: Hagens Berman Sobol Shapiro LLP
Apr 01, 2026, 09:00 ET Lost Money on Corcept Therapeutics Incorporated(CORT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
& Korsinsky, LLP notifies investors in Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated" or the "Company") (NASDAQ: CORT) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Mar 31, 2026, 17:15 ET CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April 21, 2026 lead plaintiff deadline.So what:
More news about: THE ROSEN LAW FIRM, P. A.
Mar 31, 2026, 12:00 ET Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
CORT).
More news about: Glancy Prongay Wolke & Rotter LLP
Mar 31, 2026, 09:00 ET CORT Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Corcept Therapeutics Incorporated Securities Lawsuit -- The Gross Law Firm
March 31, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Corcept Therapeutics Incorporated (NASDAQ: CORT).
More news about: The Gross Law Firm
Mar 30, 2026, 15:56 ET CORT INVESTOR ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
Corcept common stock between October 31, 2024, and December 30, 2025 (the "Class Period").Investors in Corcept (CORT) are encouraged to visit the Hagens Berman's CORT Case Page to review the allegations:
More news about: Hagens Berman Sobol Shapiro LLP
Mar 30, 2026, 04:10 ET CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
More news about: The Schall Law Firm
Mar 30, 2026, 04:09 ET Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT
CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CORT during the class period listed are encouraged
More news about: DJS Law Group LLP
Mar 27, 2026, 22:25 ET Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Corcept Therapeutics Incorporated (NasdaqCM: CORT) ("Corcept" or the "Company"), if they purchased or otherwise acquired the Company's shares between October 31, 2024 and December 30, 2025, inclusive
More news about: Kahn Swick & Foti, LLC
Mar 26, 2026, 23:04 ET CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April 21, 2026 lead plaintiff deadline.So what:
More news about: THE ROSEN LAW FIRM, P. A.
Mar 26, 2026, 16:42 ET CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
Corcept common stock between October 31, 2024, and December 30, 2025 (the "Class Period").Investors in Corcept (CORT) are encouraged to visit the Hagens Berman's CORT Case Page to review the allegations:
More news about: Hagens Berman Sobol Shapiro LLP
Mar 26, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines - CORT
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-corcept-therapeutics-incorporated-of-class-action-lawsuit-and-upcoming-deadlines--cort-302725698.htmlSOURCE
More news about: Pomerantz LLP
Mar 25, 2026, 09:00 ET Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Corcept Therapeutics Incorporated(CORT) Shareholders
& Korsinsky, LLP notifies investors in Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated" or the "Company") (NASDAQ: CORT) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP